Clear Street’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-527,202
Closed 941
2024
Q1
$0 Sell
527,202
-100
-0% -$7 ﹤0.01% 947
2023
Q4
$31.6K Sell
527,302
-1,500
-0.3% -$85 ﹤0.01% 219
2023
Q3
$32.1K Buy
528,802
+20,102
+4% +$1.29K ﹤0.01% 319
2023
Q2
$29.1K Buy
508,700
+108,700
+27% +$6.55K ﹤0.01% 522
2023
Q1
$20K Buy
400,000
+269,125
+206% +$24.2K ﹤0.01% 378
2022
Q4
$17K Sell
130,875
-3,896
-3% -$487 ﹤0.01% 414
2022
Q3
$16K Hold
134,771
﹤0.01% 518
2022
Q2
$11K Sell
134,771
-200
-0.1% -$27 ﹤0.01% 525
2022
Q1
$16K Sell
134,971
-2,493
-2% -$398 ﹤0.01% 218
2021
Q4
$25K Buy
+137,464
New +$28.4K ﹤0.01% 149

Other funds holding VHAQ.RT

Clear Street's VHAQ.RT Position: Q2 2024 in Review

Clear Street sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q2 2024, closing a stake of 527,202 shares.

Clear Street first reported a position in VHAQ.RT in Q4 2021 and held it in 10 quarters. The position peaked at $32.1K in Q3 2023. 1 fund tracked by Wall St. Rank holds VHAQ.RT as of Q2 2024.

  • Clear Street reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q2 2024 after selling out during the quarter.
  • Clear Street sold 527,202 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q2 2024.
  • Clear Street first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q4 2021 and held it in 10 quarters.
  • Clear Street's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $32.1K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q2 2024.

Based on Clear Street's 13F filing for Q2 2024, filed 12 Aug 2024.